N/A
N=250
Preoperative Survey to Evaluate Patient Allergy
Allergy Drug · Allergic Reaction · Pediatric · Surgery
Bottom Line
View on ClinicalTrials.gov: NCT05670756 ↗Enrolled (actual)
250
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: True Allergy (Consistent With an IgE-mediated Reaction) — 135 Allergies
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Survey (Other)
- Age
- Pediatric, Adult
- Sex
- All
- Sponsor
- Nationwide Children's Hospital
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY True Allergy (Consistent With an IgE-mediated Reaction) |
135 | — |
| SECONDARY Unlikely True Allergy (Less Relevant With an IgE-mediated Reaction) |
73 | — |
| SECONDARY Not True Allergy (Not Related to IgE-mediated Reaction) |
93 | — |
Summary
The study will only involve identification of the listed allergies from the electronic medical record and investigation into the symptoms that prompted this allergy listing. The purpose is to evaluate demographics and prevalence of allergies in patients presenting for surgery, evaluate the medical decision making process behind allergy identification, and determine its potential impact on perioperative care. The participants will be asked to complete a survey in REDCap using an iPad during the visit.
Eligibility Criteria
Inclusion Criteria
- Patients 0-21 years of age presenting for surgery or procedure requiring anesthesia
Exclusion Criteria
- Patients who are not able cognitively to complete the computerized survey due to physical or intellectual impairment or communication issues related to non-English speaking patients
Data sourced from ClinicalTrials.gov (NCT05670756). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.